Funder
Associazione Italiana per la Ricerca sul Cancro
Breast Cancer Research Foundation
Subject
Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference99 articles.
1. Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers;Migliaccio;BMC Med,2015
2. The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study;Finn;Lancet Oncol,2015
3. Palbociclib and letrozole in advanced breast cancer;Finn;New England J Med,2016
4. Palbociclib in hormone-receptor-positive advanced breast cancer;Turner;New England J Med,2015
5. MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR(+)/HER2(-) Metastatic Breast Cancer;Dickler;Clin Cancer Res: Off J Am Assoc Cancer Res,2017
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献